Work

A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.e13026

Authors: S. E. Minton, P. LoRusso, A. C. Lockhart, M. Saif, S. S. Krishnamurthi, C. A. Pickett-Gies, Y. Wang, S. Guan, E. Roben, M. N. Stein

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244860544

Cites:

Cited by: 12

Related to: 10